Asthma Treatment Market
Asthma Treatment Market Study by Inhaled, Oral, Intravenous, and Subcutaneous for Long-term Asthma Control Medications and and Quick-relief (Rescue) Medications from 2023 to 2033
Analysis of Asthma Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Author:
Md Sanaullah
Editor:
Anushree Karale
- FACT4422MR
- 25 Jan 2023
- Healthcare
- 170 Pages
- 39 Tables
- 102 Figures
- Forecast Value (2033): 35.4 Bn
- CAGR (2033): 3.2%
Table of Content
- 1. Preface
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Market
- 4. Market Overview
- 5. Market Outlook
- 6. Global Market Analysis and Forecasts, by Treatment Type
- 6.1. Long-term Asthma Control Medications
- 6.1.1. Inhaled Corticosteroids
- 6.1.2. Leukotriene Modifiers
- 6.1.3. Long-acting Beta Agonists
- 6.1.4. Combination Inhalers
- 6.1.5. Theophylline
- 6.1.6. Others (reslizumab, benralizumab, etc.)
- 6.2. Quick-relief (rescue) Medications
- 6.2.1. Short-acting Beta Agonists
- 6.2.2. Ipratropium (Atrovent)
- 6.2.3. Oral and Intravenous Corticosteroids
- 6.1. Long-term Asthma Control Medications
- 7. Global Market Analysis and Forecasts, by Route of Administration
- 7.1. Oral
- 7.2. Inhaled
- 7.3. Intravenous
- 7.4. Subcutaneous
- 8. Global Market Analysis and Forecasts, by Distribution Channel
- 8.1. Hospital Pharmacies
- 8.2. Retail Pharmacies
- 8.3. Online Pharmacies
- 9. Global Market Analysis and Forecasts, by Region
- 9.1. North America
- 9.2. Europe
- 9.3. Asia Pacific
- 9.4. Latin America
- 9.5. Middle East & Africa
- 10. North America Market Analysis and Forecast
- 11. Europe Market Analysis and Forecast
- 12. Asia Pacific Market Analysis and Forecast
- 13. Latin America Market Analysis and Forecast
- 14. Middle East & Africa Market Analysis and Forecast
- 15. Competition Landscape
- 15.1. AstraZeneca
- 15.2. Boehringer Ingelheim International GmbH
- 15.3. GlaxoSmithKline plc
- 15.4. Novartis AG
- 15.5. Teva Pharmaceutical Industries Ltd
- 15.6. Sumitomo Dainippon Pharma Co., Ltd
- 15.7. Merck & Co., Inc.
- 15.8. F. Hoffmann-La Roche Ltd.
- 15.9. Sanofi
- 15.10. Mylan N.V.
List Of Table
Table 01: Pipeline Analysis
Table 02: Pipeline Analysis
Table 03: Pipeline Analysis
Table 04: Global Market Value (US$ Mn) Forecast, by Treatment Type, 2023 to 2033
Table 05: Global Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2023 to 2033
Table 06: Global Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2023 to 2033
Table 07: Global Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033
Table 08: Global Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 09: Global Market Value (US$ Mn) Forecast, by Region, 2023 to 2033
Table 10: North America Market Value (US$ Mn) Forecast, by Treatment Type, 2023 to 2033
Table 11: North America Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2023 to 2033
Table 12: North America Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2023 to 2033
Table 13: North America Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033
Table 14: North America Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 15: North America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 16: Europe Market Value (US$ Mn) Forecast, by Treatment Type, 2023 to 2033
Table 17: Europe Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2023 to 2033
Table 18: Europe Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2023 to 2033
Table 19: Europe Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033
Table 20: Europe Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 21: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 22: Asia Pacific Market Value (US$ Mn) Forecast, by Treatment Type, 2023 to 2033
Table 23: Asia Pacific Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2023 to 2033
Table 24: Asia Pacific Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2023 to 2033
Table 25: Asia Pacific Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033
Table 26: Asia Pacific Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 27: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 28: Latin America Market Value (US$ Mn) Forecast, by Treatment Type, 2023 to 2033
Table 29: Latin America Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2023 to 2033
Table 30: Latin America Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2023 to 2033
Table 31: Latin America Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033
Table 32: Latin America Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 33: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 34: Middle East & Africa Market Value (US$ Mn) Forecast, by Treatment Type, 2023 to 2033
Table 35: Middle East & Africa Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2023 to 2033
Table 36: Middle East & Africa Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2023 to 2033
Table 37: Middle East & Africa Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033
Table 38: Middle East & Africa Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 39: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
List Of Figures
Figure 01: Global Market Value (US$ Mn) and Distribution Channel, by Region, 2022 and 2033
Figure 02: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 03: Global Market Value Share Analysis, by Treatment Type, 2022 and 2033
Figure 04: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Long-term Asthma Control Medications, 2023 to 2033
Figure 05: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Quick-relief (rescue) Medications, 2023 to 2033
Figure 06: Global Market Attractiveness Analysis, by Treatment Type, 2022 to 2033
Figure 07: Global Market Value Share Analysis, by Route of Administration, 2022 and 2033
Figure 08: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Inhaled, 2023 to 2033
Figure 09: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2023 to 2033
Figure 10: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intravenous, 2023 to 2033
Figure 11: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Subcutaneous, 2023 to 2033
Figure 12: Global Market Attractiveness Analysis, by Route of Administration, 2022 to 2033
Figure 13: Global Market Value Share Analysis, by Distribution Channel, 2022 and 2033
Figure 14: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2023 to 2033
Figure 15: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2023 to 2033
Figure 16: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2023 to 2033
Figure 17: Global Market Attractiveness Analysis, by Distribution Channel, 2022 to 2033
Figure 18: Global Market Value Share Analysis, by Region, 2022 and 2033
Figure 19: Global Market Attractiveness Analysis, by Region, 2022 to 2033
Figure 20: North America Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 21: North America Market Value Share Analysis, by Treatment Type, 2022 and 2033
Figure 22: North America Market Attractiveness Analysis, by Treatment Type, 2022 to 2033
Figure 23: North America Market Value Share Analysis, by Route of Administration, 2022 and 2033
Figure 24: North America Market Attractiveness Analysis, by Route of Administration, 2022 to 2033
Figure 25: North America Market Value Share Analysis, by Distribution Channel, 2022 and 2033
Figure 26: North America Market Attractiveness Analysis, by Distribution Channel, 2022 to 2033
Figure 27: North America Market Value Share Analysis, by Country, 2022 and 2033
Figure 28: North America Market Attractiveness Analysis, by Country, 2022 to 2033
Figure 29: Europe Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 30: Europe Market Value Share Analysis, by Treatment Type, 2022 and 2033
Figure 31: Europe Market Attractiveness Analysis, by Treatment Type, 2022 to 2033
Figure 32: Europe Market Value Share Analysis, by Route of Administration, 2022 and 2033
Figure 33: Europe Market Attractiveness Analysis, by Route of Administration, 2022 to 2033
Figure 34: Europe Market Value Share Analysis, by Distribution Channel, 2022 and 2033
Figure 35: Europe Market Attractiveness Analysis, by Distribution Channel, 2022 to 2033
Figure 36: Europe Market Value Share Analysis, by Country/Sub-Region, 2022 and 2033
Figure 37: Europe Market Attractiveness Analysis, by Country/Sub-region, 2022 to 2033
Figure 38: Asia Pacific Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 39: Asia Pacific Market Value Share Analysis, by Treatment Type, 2022 and 2033
Figure 40: Asia Pacific Market Attractiveness Analysis, by Treatment Type, 2023 to 2033
Figure 41: Asia Pacific Market Value Share Analysis, by Route of Administration, 2022 and 2033
Figure 42: Asia Pacific Market Attractiveness Analysis, by Route of Administration, 2022 to 2033
Figure 43: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2022 and 2033
Figure 44: Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2022 - 2033
Figure 45: Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2022 and 2033
Figure 46: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region, 2022 to 2033
Figure 47: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 48: Latin America Market Value Share Analysis, by Treatment Type, 2022 and 2033
Figure 49: Latin America Market Attractiveness Analysis, by Treatment Type, 2022 to 2033
Figure 50: Latin America Market Value Share Analysis, by Route of Administration, 2022 and 2033
Figure 51: North America Market Attractiveness Analysis, by Route of Administration, 2022 to 2033
Figure 52: Latin America Market Value Share Analysis, by Distribution Channel, 2022 and 2033
Figure 53: Latin America Market Attractiveness Analysis, by Distribution Channel, 2022 to 2033
Figure 54: Latin America Market Value Share Analysis, by Country/Sub-region, 2022 and 2033
Figure 55: Latin America Market Attractiveness Analysis, by Country/Sub-region, 2022 to 2033
Figure 56: Middle East & Africa Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 57: Middle East & Africa Market Value Share Analysis, by Treatment Type, 2022 and 2033
Figure 58: Middle East & Africa Market Attractiveness Analysis, by Treatment Type, 2022 to 2033
Figure 59: Middle East & Africa Market Value Share Analysis, by Route of Administration, 2022 and 2033
Figure 60: Middle East & Africa Market Attractiveness Analysis, by Route of Administration, 2022 to 2033
Figure 61: Middle East & Africa Market Value Share Analysis, by Distribution Channel, 2022 and 2033
Figure 62: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2022?2033
Figure 63: Middle East & Africa Market Value Share Analysis, by Country/Sub-region, 2022 and 2033
Figure 64: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2022 to 2033
Figure 65: Global Market Share, by Company, 2022
Figure 66: AstraZeneca Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 67: AstraZeneca Respiratory Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 68: AstraZeneca Breakdown of Net Sales (%), by Product Segment, 2022
Figure 69: Boehringer Ingelheim International GmbH Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 70: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Region, 2022
Figure 71: Boehringer Ingelheim International GmbH R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 72: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Business Segment, 2022
Figure 73: GlaxoSmithKline plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 74: GlaxoSmithKline plc Breakdown of Net Sales (%), by Region, 2022
Figure 75: GlaxoSmithKline plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 76: GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2022
Figure 77: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 78: Novartis AG Breakdown of Net Sales (%), by Country, 2022
Figure 79: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 80: Novartis AG Breakdown of Net Sales (%), by Business Segment, 2022
Figure 81: Teva Pharmaceutical Industries Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 82: Teva Pharmaceutical Industries Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 83: Teva Pharmaceutical Industries Ltd Breakdown of Net Sales (%), by Segment, 2022
Figure 84: Sumitomo Dainippon Pharma Co., Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2014 to 2022
Figure 85: Sumitomo Dainippon Pharma Co., Ltd Breakdown of Pharmaceutical Net Sales (%), by Region, 2017
Figure 86: Sumitomo Dainippon Pharma Co., Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014 to 2022
Figure 87: Breakdown of Sumitomo Dainippon Pharma Co., Ltd Net Sales (%), by Product Segment, 2017
Figure 88: Merck & Co., Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 89: Merck & Co., Inc. Breakdown of Net Sales (%), by Region, 2022
Figure 90: Merck & Co., Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 91: Merck & Co., Inc. Breakdown of Net Sales (%), by Business Segment, 2022
Figure 92: F. Hoffmann-La Roche Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 93: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (%), by Region, 2022
Figure 94: F. Hoffmann-La Roche Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 95: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (%), by Business Segment, 2022
Figure 96: Sanofi Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 97: Sanofi Breakdown of Net Sales (%), by Region, 2022
Figure 98: Sanofi Revenue Breakdown of Net Sales (%), by Business segment, 2022
Figure 99: Sanofi R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 100: Mylan N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 101: Mylan N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 102: Mylan N.V. Breakdown of Net Sales (%), by Region, 2022
Asthma Treatment Market